Severe overdosage with the antiepileptic drug oxcarbazepine
Open Access
- 1 September 2004
- journal article
- case report
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 58 (3) , 329-331
- https://doi.org/10.1111/j.1365-2125.2004.02129.x
Abstract
Few published human data are available concerning the acute toxicity of the new antiepileptic drug oxcarbazepine of which the metabolite 10- monohydroxy derivate (MHD) is the pharmacologically effective compound. Two hours after a documented overdosage of more than 100 tablets oxcarbazepine, the serum level of the parent compound was 10-fold higher than the therapeutic dosage (31.6 mg l(-1)). However, the concentration of MHD, which peaked 7 h after intake, was only twofold higher (59.0 mg l(-1)). No life-threatening situations occurred and the patient fully recovered. The fact that oxcarbazepine is a prodrug and that the formation of the active MHD metabolite is a rate-limiting process may contribute to the relative low toxicity of the drug in overdose.Keywords
This publication has 8 references indexed in Scilit:
- Oxcarbazepine, risperidone and atenolol overdose with benign outcomeInternational Journal of Neuropsychopharmacology, 2003
- Therapeutic Drug Monitoring of the Newer Antiepileptic DrugsTherapeutic Drug Monitoring, 2003
- Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjectsInt. Journal of Clinical Pharmacology and Therapeutics, 2002
- Oxcarbazepine in the Treatment of EpilepsyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Hyponatremia induced by oxcarbazepine in childrenEpilepsy Research, 1998
- Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizuresEuropean Journal of Pharmacology, 1994
- Oxcarbazepine: Mechanisms of ActionEpilepsia, 1994
- New Concepts in DepressionInternational Clinical Psychopharmacology, 1990